Several metabolic pathways are thought to mediate glucose's ability to provoke metabolic dysfunction, insulin resistance, and T2DM including the polyol, AGE, PKC, and hexosamine biosynthetic pathways [42]. This evidence concerns the gene PRRT2 and Insulin resistance.